Hi Rocketman2,
I tried to address some of your comments in a comment to my most recent SA article (http://seekingalpha.com/article/3780396-resverlogix-rvxminus-208-epigenetics-age-related-diseases).
As for what caused Hepalink to invest in Resverlogix, you have to read the entire SA article - the short answer, though, is: The science.
Best regards,
BKC